|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.70 BRL | +0.57% |
|
+0.79% | +1.12% |
| 07-16 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| 07-13 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +0.57% | +0.79% | +1.12% | +12.67% | +46.85% | 198B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
